Report : North America Hemostasis Analyzers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Laboratory Analyzer [Automated Systems, Semi-Automated Systems, and Manual Systems]), and Point-of-Care Testing Systems), Test (Activated Partial Thromboplastin Time, D-Dimer Test, Fibrinogen Test, Prothrombin Time (PT) Test, and Others), and End User (Hospitals/ Clinics, Independent Diagnostic Laboratories, Home Care Setting, and Others)
Laboratory Analyzer segment has the Largest Share of Product Type in the North America Hemostasis Analyzers Market during 2020–2028
According to a new market research study on “North America Hemostasis Analyzers Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product Type, Test, End User and Country” is expected to reach US$ 2,462.45 million by 2028 from US$ 1,293.76 million in 2021. The market is estimated to grow at a CAGR of 9.6% from 2021 to 2028. The report provides trends prevailing in the North America hemostasis analyzers market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to rising number of cardiovascular diseases and rise in the geriatric population are the key factors driving the market growth. However, the market is expected to experience slow growth during the forecast period owing to high cost of fully automated hemostasis analyzer.
The North American region is highly affected due to the outbreak of the Covid-19 pandemic. Countries such as the US and Canada reported the highest numbers of COVID-19 positive cases. The US-registered highest number of deaths due to the COVID-19 pandemic. The chaotic situation was created in the medical industry across the countries, increased the demand for diagnosing and therapeutic devices have dramatically increased in the hospitals. For instance, the demand for ventilators, respirators, and in vitro diagnostic (IVD) tests has risen drastically in hospitals across the countries. On the other hand, demand for personal protective kits has significantly gone up. The life sciences segment thrives due to increased demand for in-vitro diagnostic products and rising research and development activities worldwide.
The market for North America Hemostasis Analyzers Market is segmented into the product type, test, end user and country. Based on product type, the North America Hemostasis Analyzers Market is segmented into laboratory analyzer, and point-of-care testing systems, whereas laboratory analyzer sub segmented into automated systems, semi-automated systems, and manual systems. In 2021, the laboratory analyzer segment accounted for the largest market share. The growth of these segments is attributed to an increase in the prevalence of chronic illnesses like blood disorders and cardiovascular diseases, development of point of care (POC) coagulation testing, and the surge in laboratory automation is likely to create opportunity in the forecast year. However the point-of-care testing systems segment is estimated to register the highest CAGR during the forecast period.
Siemens Healthineers AG , Abbott , Sysmex Corporation , Nihon Kohden Corporation ,THERMO FISHER SCIENTIFIC INC. ,HOFFMANN-LA ROCHE LTD. , Instrumentation Laboratory Company ,Helena Laboratories Corporation , Diagnostica Stago, Inc .,International Technidyne Corporation. Among the leading companies in the North America hemostasis analyzers market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
The market for North America hemostasis analyzers market is segmented into product type, test, and end user. Based on product type, the North America hemostasis analyzers market is segmented into laboratory analyzer [automated systems, semi-automated systems, and manual systems], and point-of-care testing systems. Based on test, the North America hemostasis analyzers market is segmented into activated partial thromboplastin time, d-dimer test, fibrinogen test, prothrombin time (PT) test, and others. Based on end user, the North America hemostasis analyzers market is segmented into hospitals/ clinics, independent diagnostic laboratories, home care setting, and others. By Geographically, North America hemostasis analyzers market is segmented into (US, Canada, and Mexico).
Contact Person: Sameer Joshi
Email Id: firstname.lastname@example.org